Mo1844 - Drug Survival and Immunogenicity after Switching from Remicade ® to Biosimilar Ct-P13 in Inflammatory Bowel Disease Patients: Two Year Follow-Up of a Prospective Observational Cohort Study

2018 ◽  
Vol 154 (6) ◽  
pp. S-822
Author(s):  
Lisa Smits ◽  
Lauranne Derikx ◽  
Aura van Esch ◽  
Joost Drenth ◽  
Ronald Boshuizen ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Cohort Study ◽  
Bowel Disease ◽  
Observational Cohort Study ◽  
Prospective Observational Cohort Study ◽  
Drug Survival ◽  
Observational Cohort ◽  
Inflammatory Bowel

Mo1884 - Drug Survival of Vedolizumab-Treated Inflammatory Bowel Disease Patients in a Nationwide Observational Cohort Study: ICC Case Series

2018 ◽  
Vol 154 (6) ◽  
pp. S-838
Author(s):  
Vince Biemans ◽  
Christien Janneke Van Der Woude ◽  
Gerard Dijkstra ◽  
Andrea Van Der Meulen ◽  
Bas Oldenburg ◽  
...  
Keyword(s):  
Inflammatory Bowel Disease ◽  
Cohort Study ◽  
Bowel Disease ◽  
Case Series ◽  
Observational Cohort Study ◽  
Drug Survival ◽  
Observational Cohort ◽  
Inflammatory Bowel
Sign in / Sign up

Export Citation Format

Share Document